Fundz

Asher Biotherapeutics, Inc. reported raising $490,000 in an initial SEC Form D filing, from an offering of $3 Million

PRIVATESep 05, 2019$490K of $3M raised

Amount Raised

$490,000

$490,000 sold, per SEC Form D (first sale Sep 5, 2019)

Round Type

Seed

South San FranciscoBiotechnology

Quick answer

Asher Biotherapeutics, Inc. raised $490,000 in a Seed round, dated September 5, 2019. Asher Biotherapeutics, Inc. is based in South San Francisco, California, United States.

How much did Asher Biotherapeutics, Inc. raise?
Asher Biotherapeutics, Inc. raised $490,000 in a Seed round on September 5, 2019.
What does Asher Biotherapeutics, Inc. do?
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases.
Where is Asher Biotherapeutics, Inc. based and how big is it?
Asher Biotherapeutics, Inc. is based in South San Francisco, California, United States.
Who are the decision-makers at Asher Biotherapeutics, Inc?
Fundz holds 1 contact at Asher Biotherapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Asher Biotherapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Icosavax, Inc. raised $30M on October 18, 2019.
  • Cell Source, Inc. raised $8.9M on October 18, 2019.
  • Eccrine Systems, Inc. raised $1.9M (Seed) on October 18, 2019.
  • Biogix, Inc. raised $2M (Seed) on October 17, 2019.
  • Convexity Scientific Inc. raised $3.5M (Seed) on October 16, 2019.
  • Creatus Biosciences Inc. raised $218K (Pre-Seed) on October 16, 2019.

Who to call at Asher Biotherapeutics, Inc., and when

A new round usually means Asher Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Asher Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Asher Biotherapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Asher Biotherapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Asher Biotherapeutics, Inc.

Location

650 GATEWAY BLVD., SUITE 100

South San Francisco, California, United States

About

Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Asher Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCraig G., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Asher Biotherapeutics, Inc.'s next move

See what Strategic adds

Asher Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.